UCPI leads the way in Brachytherapy, an innovative and highly effective treatment for early-stage prostate cancer. This advanced therapy involves the precise placement of radioactive seeds directly into the prostate gland. These seeds emit targeted radiation over time, effectively destroying cancer cells while minimizing damage to surrounding healthy tissues.
Unlike traditional external radiation therapy, Brachytherapy allows for higher doses of radiation in a more confined area. This means reduced side effects, shorter recovery times, and excellent outcomes for patients diagnosed in the early stages of prostate cancer.
With state-of-the-art facilities and a team of experienced specialists, UCPI (Urologic Center of the Philippines, Inc.) is proud to offer this cutting-edge option as part of its commitment to providing world-class urologic care in the Philippines. Patients can now access a safer, less invasive, and highly effective alternative to surgery or conventional radiation.
Brachytherapy represents hope—a step forward in the fight against prostate cancer, made possible through UCPI’s dedication to innovation and excellence in patient care.
